Clinical trial
Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR
NCT00425568 · Lamm, Steven, M.D., Other · Completed
Key facts
| NCT number | NCT00425568 |
|---|---|
| Title | Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR |
| Official title | Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR) |
| Lead sponsor | Lamm, Steven, M.D., Other |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypogonadism |
| Intervention type | Drug |
| Interventions | AndroGel (Transdermal Testosterone Gel) |
| Enrollment | 30 |
| Start date | Dec 1, 2005 |
| First posted | Jan 23, 2007 |
| Last update posted | Aug 8, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: